Skip to content

Application to Improve Patient Engagement and Decrease Postoperative Opioid Consumption in Patients for Colorectal Surgery

An Educational Mobile Application to Improve Patient Engagement and Decrease Postoperative Opioid Consumption in Patients Enrolled in an Enhanced Recovery After Surgery (ERAS) Pathway for Colorectal Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06350916
Enrollment
75
Registered
2024-04-08
Start date
2021-01-28
Completion date
2021-10-01
Last updated
2024-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Surgery

Brief summary

The purpose of this study is to evaluate whether patient-centered educational material delivered before and immediately after surgery can help improve outcomes for patients undergoing colorectal surgery.

Detailed description

To analyze the impact of implementation of patient-centered educational material delivered the SeamlessMD® mobile application on perioperative Enhanced Recovery After Surgery (ERAS) metric completion rates among patients undergoing elective colorectal surgery. This is a non-interventional, prospective feasibility study. The planned study period will encompass adult patients (\>18 years) scheduled to undergo an elective colorectal surgery procedure at CMC-Main during the six-month period of December 2020 to May 2021. Patients enrolling in SeamlessMD will be prompted by the mobile app to electronically complete a validated quality-of-life assessment, the Quality of Recovery (QoR-15) evaluation, five days prior to surgery, three days postoperatively, and 30 days postoperatively.

Interventions

BEHAVIORALSeamlessMD® Mobile Application

Mobile cloud-based applications (apps), such as SeamlessMD®, are readily accessible on smart phones and offer an innovative strategy to encourage and track patient adherence to recommended ERAS components pre- and postoperatively.

Sponsors

Atrium Health Levine Cancer Institute
CollaboratorOTHER
Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients (\>18 years old) * Scheduled to undergo an elective colorectal surgery procedure (for benign or malignant colon or rectal pathology) at CMC-Main by one of the 5 participating colorectal surgeons (Davis, Hill, Kasten, Salo, Squires) * Ability to provide informed consent

Exclusion criteria

* Emergent, non-elective colorectal procedures * Non-English speaking

Design outcomes

Primary

MeasureTime frameDescription
Perioperative ERAS metric completion rate30 Days Following Hospital DischargeCompletion rate for perioperative ERAS metrics
Postoperative hospital length of stay30 Days Following Hospital DischargePostoperative hospital length of stay
Postoperative complications30 Days Following Hospital DischargeOccurrence of postoperative complications within 30 days, classified as Clavien-Dindo Grade I-V
30-day readmission30 Days Following Hospital DischargeReadmission to any hospital facility as inpatient within 30 days of surgery

Secondary

MeasureTime frameDescription
Postoperative Opioid Consumption30 Days Following Hospital DischargePostoperative opioid consumption in morphine equivalent daily doses (MEDDs) as extracted from the medical administration record (MAR) for the inpatient hospitalization period

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026